Reconstructed skin models as emerging tools for drug absorption studies

Expert Opinion on Drug Metabolism and Toxicology

Volumn 9, Issue 10, 2013, Pages 1255-1263

  Küchler, Sarah ^a   Strüver, Kay ^b   Friess, Wolfgang ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease models; in vitro; Reconstructed skin models; Skin absorption testing; Transdermal drug delivery

Indexed keywords

BENZOIC ACID; CAFFEINE; DIGOXIN; FLUFENAMIC ACID; NICOTINE; TESTOSTERONE;

ARTIFICIAL MEMBRANE; DRUG ABSORPTION; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MODEL; NONHUMAN; RELIABILITY; REVIEW; SKIN ABSORPTION; SKIN PERMEABILITY; VALIDATION PROCESS;

ADMINISTRATION, CUTANEOUS; ANIMALS; HUMANS; MODELS, ANIMAL; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION; XENOBIOTICS;

EID: 84884253454     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2013.816284     Document Type: Review

References (69)

1. Spiewak R. Pesticides as a cause of occupational skin diseases in farmers. Ann Agric Environ Med 2001;8(1):1-5
2. Walters KA, Roberts MS. The structure and function of skin. Dermatological and transdermal formulations. Marcel Dekker, Inc., New York; 2002
3. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: Theory andinvitro experimental measurement. AIChE J 1975;21(5):985-96
4. Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm 2012;435(1):3-9
5. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56(5):675-711
6. Schätzlein A, Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: A high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br J Dermatol 1998;138(4):583-92
7. Lademann J, Richter H, Schanzer S, et al. Penetration and storage of particles in human skin: Perspectives and safety aspects. Eur J Pharm Biopharm 2011;77(3):465-8
8. Patzelt A, Richter H, Knorr F, et al. Selective follicular targeting by modification of the particle sizes. J Control Release 2011;150(1):45-8
9. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992;9(5):663-9
10. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000;9(3):165-9
11. Williams FM. In vitro studies-how good are they at replacing in vivo studies for measurement of skin absorption? Environ Toxicol Pharmacol 2006;21(2):199-203
12. Godin B, Touitou E. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007;59(11):1152-61
13. Ng SF, Rouse JJ, Sanderson FD, Eccleston GM. The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study. Arch Pharm Res 2012;35(4):579-93
14. Patzelt A, Lademann J. Drug delivery to hair follicles. Expert Opin Drug Deliv 2013;10(6):787-97
15. OECD. Guidance document for the conduct of skin absorption studies. Series on testing assessment No. 28. OECD, Paris, France; 2003
16. Schäfer-Korting M, Mahmoud A, Lombardi Borgia S, et al. Reconstructed epidermis and full-thickness skin for absorption testing: Influence of the vehicles used on steroid permeation. Altern Lab Anim 2008;36(4):441-52
17. Franz TJ, Lehman PA, Raney SG. Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol 2009;22(5):276-86
18. Halkier-Sorensen L. Dermatopharmacology of topical preparations: A product development oriented approach. In: Gabard B, editor. The absolute fundamentals of transdermal pemeation. Springer, New York; 2000
19. Feldmann RJ, Maibach HI. Percutaneous penetration of steroids in man. J Invest Dermatol 1969;52(1):89-94
20. Netzlaff F, Schaefer UF, Lehr CM, et al. Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments. Altern Lab Anim 2006;34(5):499-513
21. Schäfer-Korting M, Küchler S. Alternatives for absorption testing. In: Maguire T, Novik E, editors. Alternative technologies to animal testing: Methods in bioengineering. Artech House Boston, London; 2010. p. 227-38
22. Schreiber S, Mahmoud A, Vuia A, et al. Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro 2005;19(6):813-22
23. Oji V, Eckl KM, Aufenvenne K, et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: Unraveling the peeling skin disease. Am J Hum Genet 2010;87(2):274-81
24. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005;110(1):151-63
25. Huong SP, Bun H, Fourneron JD, et al. Use of various models for in vitro percutaneous absorption studies of ultraviolet filters. Skin Res Technol 2009;15(3):253-61
26. Lai J, Maibach HI. Experimental models in predicting topical antifungal efficacy: Practical aspects and challenges. Skin Pharmacol Physiol 2009;22(5):231-9
27. Schäfer-Korting M, Bock U, Gamer A, et al. Reconstructed human epidermis for skin absorption testing: Results of the German prevalidation study. Altern Lab Ani 2006;34(3):283-94
28. Wester RC, Christoffel J, Hartway T, et al. Human cadaver skin viability for in vitro percutaneous absorption: Storage and detrimental effects of heat-separation and freezing. Pharm Res 1998;15(1):82-4
29. Schäfer-Korting M, Bock U, Diembeck W, et al. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern Lab Ani 2008;36(2):161-87
30. Singh S, Zhao K, Singh J. In vitro permeability and binding of hydrocarbons in pig ear and human abdominal skin. Drug Chem Toxicol 2002;25(1):83-92
31. Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicol In Vitro 2009;23(1):1-13
32. Rigg PC, Barry BW. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol 1990;94(2):235-40
33. Roberts ME, Mueller KR. Comparisons of in vitro nitroglycerin (TNG) flux across yucatan pig, hairless mouse, and human skins. Pharm Res 1990;7(6):673-6
34. Barber ED, Teetsel NM, Kolberg KF, Guest D. A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Fundam Appl Toxicol 1992;19(4):493-7
35. Kietzmann M, Loscher W, Arens D, et al. The isolated perfused bovine udder as an in vitro model of percutaneous drug absorption. Skin viability and percutaneous absorption of dexamethasone, benzoyl peroxide, and etofenamate. J Pharmacol Toxicol Methods 1993;30(2):75-84
36. Auxenfans C, Fradette J, Lequeux C, et al. Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Eur J Dermatol 2009;19(2):107-13
37. Van Gele M, Geusens B, Brochez L, et al. Three-dimensional skin models as tools for transdermal drug delivery: Challenges and limitations. Expert Opin Drug Deliv 2011;8(6):705-20
38. Bellas E, Seiberg M, Garlick J, Kaplan DL. In vitro 3D full-thickness skin-equivalent tissue model using silk and collagen biomaterials. Macromol Biosci 2012;12(12):1627-36
39. Spielmann H, Hoffmann S, Liebsch M, et al. The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Altern Lab Ani 2007;35(6):559-601
40. Ackermann K, Borgia SL, Korting HC, et al. The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol 2009;23(2):105-12
41. OECD. OECD guideline for the testing of chemicals, No. 431, In vitro skin corrosion; human skin model test. OECD; Paris, France: 2004. p. 8
42. OECD. OECD guideline for testing of chemicals, No.432, In vitro 3T3 NRU phototoxicity test. OECD, Paris, France; 2004
43. Asbill C, Kim N, El-Kattan A, et al. Evaluation of a human bio-engineered skin equivalent for drug permeation studies. Pharm Res 2000;17(9):1092-7
44. Ponec M, Boelsma E, Gibbs S, Mommaas M. Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002;15(Suppl1):4-17
45. Bouwstra JA, Gooris GS, Weerheim A, et al. Characterization of stratum corneum structure in reconstructed epidermis by X-ray diffraction. J Lipid Res 1995;36(3):496-504
46. Thakoersing VS, van Smeden J, Mulder AA, et al. Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents. J Invest Dermatol 2013;133(1):59-67
47. Thakoersing VS, Gooris GS, Mulder A, et al. Unraveling barrier properties of three different in-house human skin equivalents. Tissue Eng Part C Methods 2012;18(1):1-11
48. Shiu YT. Mechanical forces on cells. In: Dorf RC, editor. Tissue engineering and artifical organs. CRC Press Taylor and Francis Group, Boca Raton, Florida, USA; 2006
49. Huh D, Matthews BD, Mammoto A, et al. Reconstituting organ-level lung functions on a chip. Science 2010;328(5986):1662-8
50. Hronik-Tupaj M, Kaplan DL. A review of the responses of two- and three-dimensional engineered tissues to electric fields. Tissue Eng Part B Rev 2012;18(3):167-80
51. Ingber DE. Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci 2003;116(PT8):1397-408
52. Davisson T, Kunig S, Chen A, et al. Static and dynamic compression modulate matrix metabolism in tissue engineered cartilage. J Orthop Res 2002;20(4):842-8
53. Gattu S, Maibach HI. Modest but increased penetration through damaged skin: An overview of the in vivo human model. Skin Pharmacol Physiol 2011;24(1):2-9
54. Küchler S, Henkes D, Eckl KM, et al. Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Ani 2011;39(5):471-80
55. Mildner M, Jin J, Eckhart L, et al. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 2010;130(9):2286-94
56. Brown SJ, McLean WH. One remarkable molecule: Filaggrin. J Invest Dermatol 2012;132(3 PT2):751-62
57. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38(4):441-6
58. Chiang A, Tudela E, Maibach HI. Percutaneous absorption in diseased skin: An overview. J Appl Toxicol 2012;32(8):537-63
59. de Jager MW, Gooris GS, Dolbnya IP, et al. Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J Lipid Res 2004;45(5):923-32
60. de Jager MW, Gooris GS, Ponec M, Bouwstra JA. Lipid mixtures prepared with well-defined synthetic ceramides closely mimic the unique stratum corneum lipid phase behavior. J Lipid Res 2005;46(12):2649-56
61. Jaeckle E, Schaefer UF, Loth H. Comparison of effects of different ointment bases on the penetration of ketoprofen through heat-separated human epidermis and artificial lipid barriers. J Pharm Sci 2003;92(7):1396-406
62. Engelbrecht TN, Schroeter A, Hauss T, Neubert RH. Lipophilic penetration enhancers and their impact to the bilayer structure of stratum corneum lipid model membranes: Neutron diffraction studies based on the example oleic acid. Biochim Biophys Acta 2011;1808(12):2798-806
63. Ochalek M, Heissler S, Wohlrab J, Neubert RH. Characterization of lipid model membranes designed for studying impact of ceramide species on drug diffusion and penetration. Eur J Pharm Biopharm 2012;81(1):113-20
64. Janusova B, Zbytovska J, Lorenc P, et al. Effect of ceramide acyl chain length on skin permeability and thermotropic phase behavior of model stratum corneum lipid membranes. Biochim Biophys Acta 2011;1811(3):129-37
65. Sugibayashi K, Todo H, Oshizaka T, Owada Y. Mathematical model to predict skin concentration of drugs: Toward utilization of silicone membrane to predict skin concentration of drugs as an animal testing alternative. Pharm Res 2010;27(1):134-42
66. Schwarb FP, Gabard B, Rufli T, Surber C. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations. Dermatology 1999;198(1):44-51
67. Smith JC, Irwin WJ. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin. Int J Pharm 2000;210(1-2):69-82
68. Guzek DB, Kennedy AH, McNeill SC, et al. Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results. Pharm Res 1989;6(1):33-9
69. Bätz FM, Klipper W, Korting HC, et al. Esterase activity in excised and reconstructed human skin - Biotransformation of prednicarbate and the model dye fluorescein diacetate. Eur J Pharm Biopharm 2013;84(2):374-85